Ligand validation:8TFA

U6J: (1r,2R,3S,4r,5R,6S)-4-hydroxy-2,3,5,6-tetrakis(phosphonooxy)cyclohexyl trihydrogen diphosphate

U6J is a Ligand Of Interest in 8TFA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TFA_U6J_A_401	93%	18%	0.078	0.974	2.09	1.43	7	6	2	0	100%	1
6WO8_U6J_A_401	98%	19%	0.063	0.987	2.04	1.45	11	10	0	0	100%	1
8T98_U6J_A_401	93%	37%	0.087	0.98	1.35	1.14	6	6	1	0	100%	1
7MOH_U6J_B_501	77%	23%	0.125	0.966	2.08	1.13	11	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.